The Relationship of DASH and Mediterranean Diet Score With Serum Adiponectin Levels in Patients With Spinal Cord Injury

Study Overview
=================
Brief Summary
-----------------
The aim of this study is to reveal the relationship of DASH and Mediterranean diet score with anthropometric measurements and serum adiponectin level in individuals with spinal cord injury. This research was planned as a cross-sectional, case-control study. With the data to be obtained from the research, information will be obtained about the hormonal or biochemical basis of metabolic disorders such as atherosclerosis and insulin resistance that may occur in individuals with spinal cord injury in the long term. 20 individuals with Spinal Cord Injury will be included in the study, and the results of the patients will be compared with 20 healthy individuals. In order to determine the food consumption status of the patients, a 1-day food consumption record will be requested. DASH diet score and Mediterranean diet score will be calculated from dietary records. After 8 hours of fasting, 3 ml of peripheral blood will be taken for the measurement of adiponectin between 08:00 and 09:00 in the morning from the individuals in the study and control groups. Adiponectin level will be measured and its correlation with DASH diet score and Mediterranean diet score will be examined.

Official Title
-----------------
The Relationship of DASH and Mediterranean Diet Score With Serum Adiponectin Levels in Patients With Spinal Cord Injury

Conditions
-----------------
Spinal Cord Injuries

Intervention / Treatment
-----------------
* Other: Keeping a 1-day food consumption record by the patient
* Other: Measurement of adiponectin level


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Inclusion criteria (Study group) Having spent at least 6 months after spinal cord injury 1st motor neuron injury Being between the ages of 18-65 Giving consent to participate in the study Inclusion criteria (Control group) Being between the ages of 18-65 Giving consent to participate in the study Exclusion Criteria: Exclusion criteria (Study group) Having an additional disease to the spinal cord injury Having a 2nd motor neuron lesion Exclusion criteria (Control group) • Having any disease

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients with spinal cord injury<br> | Other: Keeping a 1-day food consumption record by the patient<br>* Checking and receiving the 1-day food consumption record recorded by the patient by the researcher<br>Other: Measurement of adiponectin level<br>* Adiponectin level will be measured for each group<br>|
| Healthy group<br> | Other: Keeping a 1-day food consumption record by the patient<br>* Checking and receiving the 1-day food consumption record recorded by the patient by the researcher<br>Other: Measurement of adiponectin level<br>* Adiponectin level will be measured for each group<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Adiponectin level | Adiponectin level will be measured from peripheral blood | Will be measured at inclusion | 
| DASH diet score | Will be measured at inclusion from one day dietary record | Will be measured at inclusion from one day dietary record | 
| Mediterrenian diet score | Will be measured at inclusion from one day dietary record | Will be measured at inclusion from one day dietary record | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Whole blood count | Will be measured at inclusion | Will be measured at inclusion | 
| Fasting blood glucose | Will be measured at inclusion | Will be measured at inclusion | 
| Total cholesterol | Will be measured at inclusion | Will be measured at inclusion | 
| LDL | Will be measured at inclusion | Will be measured at inclusion | 
| HDL | Will be measured at inclusion | Will be measured at inclusion | 
| TG | Will be measured at inclusion | Will be measured at inclusion | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Adiponectin